¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"silent mutation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mutation genetics
    º¯ÀÌÀ¯ÀüÇÐ
  • mutation rate
    µ¹¿¬º¯ÀÌÀ²
  • natural mutation
    ÀÚ¿¬µ¹¿¬º¯ÀÌ
  • nonsense mutation
    ¹«Àǹ̵¹¿¬º¯ÀÌ, ³Í¼¾½ºµ¹¿¬º¯ÀÌ
  • plaque morphology mutation
    ÆÇÇüŵ¹¿¬º¯ÀÌ, ÇöóÅ©Çüŵ¹¿¬º¯ÀÌ
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • polar mutation
    ±Ø¼ºµ¹¿¬º¯ÀÌ
  • population mutation
    Áý´Üµ¹¿¬º¯ÀÌ
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ
  • reverse mutation
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • somatic mutation
    ü¼¼Æ÷µ¹¿¬º¯ÀÌ
  • somatic mutation theory
    ü¼¼Æ÷µ¹¿¬º¯À̼³
  • spontaneous mutation
    ÀÚ¿¬µ¹¿¬º¯ÀÌ
  • suppressor mutation
    ¾ïÁ¦(µ¹¿¬)º¯ÀÌ
  • temperature-sensitive mutation
    ¿Âµµ¹Î°¨µ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • induced mutation
    À¯¹ßµ¹¿¬º¯ÀÌ
  • loss mutation
    »ó½Çµ¹¿¬º¯ÀÌ
  • mutation
    µ¹¿¬º¯ÀÌ
  • missense mutation
    °ú¿Àµ¹¿¬º¯ÀÌ
  • multiple allelic mutation
    ¹µ¸Â¼¶µ¹¿¬º¯ÀÌ
  • mutation rate
    µ¹¿¬º¯ÀÌÀ²
  • natural mutation
    ÀÚ¿¬µ¹¿¬º¯ÀÌ
  • nonsense mutation
    ¹«Àǹ̵¹¿¬º¯ÀÌ
  • plaque morphology mutation
    (¢¡plaque-type mutation) ÇöóÅ©Çüµ¹¿¬º¯ÀÌ
  • plaque-type mutation
    ÇöóÅ©Çüµ¹¿¬º¯ÀÌ
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • polar mutation
    ±Ø¼ºµ¹¿¬º¯ÀÌ
  • population mutation
    Áý´Ü±ºµ¹¿¬º¯ÀÌ
  • reading frame mutation
    ÇØµ¶Æ²µ¹¿¬º¯ÀÌ
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • silent stone
    ¹«Áõ»ó°á¼®(ÙíñøßÒÌ¿à´), Àẹ¼º °á¼®.
  • silent stone
    ¹«Áõ»ó°á¼®(ÙíñøßÒÌ¿à´), Àẹ¼º °á¼®(íÖÜÑàõÌ¿à´)
  • silent suicide
    Ä¡·á°ÅºÎÀÚ»ì
  • silent ulcer
    ¹«Áõ»ó±Ë¾ç(ÙíñøßÒÏ÷åË).
  • silent ulcer
    ¹«Áõ»ó±Ë¾ç(ÙíñøßÒÏ÷åË)
  • back mutation
    ¿ªº¯ÀÌ
  • chromosomal mutation
    ¿°»öü(µ¹¿¬)º¯ÀÌ.
  • cold-sensitive mutation
    ÇÑ·©°¨¼ö¼º µ¹¿¬º¯ÀÌ
  • complementation of virus mutation
    ¹ÙÀÌ·¯½ºº¯ÀÌ (Áõ½Ä)º¸¿Ï(¡­ñòãÖÜÍèÇ).
  • conditional lethal mutation
    Á¶°ÇÄ¡»ç µ¹¿¬º¯ÀÌ
  • conditional mutation
    Á¶°Çµ¹¿¬º¯ÀÌ
  • dominant mutation
    ¿ì¼º[µ¹¿¬]º¯ÀÌ
  • dominant mutation
    ¿ì¼º(µ¹¿¬)º¯ÀÌ(¡­ÔÍæ×ܨì¶).
  • drift mutation
    ¿¬¼Óº¯ÀÌ(ææáÙܨì¶).
  • frameshift mutation
    ÇØµ¶Æ² µ¹¿¬º¯ÀÌ, ÇÁ·¹ÀÓ½¬ÇÁÆ® µ¹¿¬º¯ÀÌ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • phase shift mutation
    »óÀ̵¿ º¯ÀÌ(ßÓì¹ÔÑܨì¶)
  • pleiotropic mutation
    ´ÙÇüÁú¼º º¯ÀÌ(Òýû¡òõàõܨì¶)
  • point mutation
    Á¡º¯ÀÌ(ïÃܨì¶)
  • polarity mutation
    ±Ø¼º º¯ÀÌ(пàõܨì¶)
  • polar mutation
    ±Ø¼º º¯ÀÌ(пàõܨì¶)
  • promoter-down mutation
    ÇÁ·Î¸ðÅÍ ±â´ÉÀúÇÏ º¯ÀÌ(ѦÒöî¸ù»Ü¨ì¶)
  • promoter mutation
    ÇÁ·Î¸ðÅÍ º¯ÀÌ(ܨì¶)
  • promoter-up mutation
    ÇÁ·Î¸ðÅÍ ±â´É»ó½Âº¯ÀÌ(ѦÒöß¾ã°Ü¨ì¶)
  • Quaking mutation
    ÄùÀÌÅ· º¯ÀÌ(ܨì¶).
  • samesense mutation
    µ¿ÀÇ º¯ÀÌ(ÔÒëòܨì¶)
  • second-site mutation
    µÑ° ÀÚ¸® º¯ÀÌ(ܨì¶)
  • semilethal mutation
    ÁØÄ¡»ç º¯ÀÌ(ñÞöÈÞÝܨì¶)
  • sign mutation
    ½ÅÈ£º¯ÀÌ(ãáûÜܨì¶)
  • single-site mutation
    ¿ÜÀÚ¸® º¯ÀÌ(ܨì¶)
  • somatic mutation
    ü¼¼Æ÷ º¯ÀÌ(ô÷á¬øàܨì¶)
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
SMART Somatic Mutation And Recombination Test
MCR mutation cluster region
M(f) mutation frequency
Tfm testicular feminization mutation
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
somatic mutation Mutation that occurs in the somatic tissues of an organism and that will not, therefore, be heritable, since it is not present in the germ line. Some neoplasia is due to somatic mutation, a more conspicuous example is the reversion of some branches of variegated shrubs to the wild type (completely green) phenotype. Somatic mutation is probably also important in generating diversity in V gene regions of immunoglobulins.
(18 Nov 1997)
somatic mutation theory of cancer That cancer is caused by a mutation or mutations in the body cells (as opposed to germ cells), especially nonlethal mutations associated with increased proliferation of the mutant cells.
(05 Mar 2000)
spontaneous mutation A mutation which occurs by itself without first being affected by a mutagen, for example during the process of DNA replication. Spontaneous mutations arise at a remarkably constant rate. The rate that spontaneous mutations arise has been used as an evolutionary clock to estimate how closely related two (or more) separate species are to each other.
(09 Oct 1997)
natural mutation A mutation which occurs by itself without first being affected by a mutagen, for example during the process of DNA replication. Spontaneous mutations arise at a remarkably constant rate. The rate that spontaneous mutations arise has been used as an evolutionary clock to estimate how closely related two (or more) separate species are to each other.
(09 Oct 1997)
neutral mutation A mutation that has no selective advantage or disadvantage. Considerable controversy surrounds the question of whether such mutations can exist.
(18 Nov 1997)
new mutation Redundant term for a heritable trait present in the offspring but in neither parent, i.e., not a pre-existing mutant form inherited.
(05 Mar 2000)
substitution mutation A mutation caused by a nucleotide base being replaced by a different one.
(09 Oct 1997)
nonsense mutation <molecular biology> A mutation that causes a polypeptide chain to be ended prematurely.
(13 Nov 1997)
null mutation Change in a gene that leads to nothing, for example to no enzyme or to a nonfunctioning enzyme.
(12 Dec 1998)
suppressor mutation <molecular biology> Mutation that alleviates the effect of a primary mutation at a different locus.
May be through almost any mechanism that can give a primary mutation, but perhaps the most interesting class are the amber and ochre supressors, where the anticodon of the tRNA is altered so that it mis reads the termination codon and inserts an amino acid, preventing premature termination of the peptide chain.
(18 Nov 1997)
deletion mutation <molecular biology> A mutation in which one or more (sequential) nucleotides is lost by the genome. If the number lost is not divisible by 3 and is in a coding region, the result is a frameshift mutation.
(18 Nov 1997)
down promoter mutation <molecular biology> A mutation (a change in base pair sequence) in a promoter region, this results in lower gene expression (less transcription of the gene occurs).
(09 Oct 1997)
induced mutation A mutation caused by exposure to a mutagen.
(05 Mar 2000)
insertion mutation A mutation caused by the insertion of at least one extra nucleotide basein a DNA sequence.
(09 Oct 1997)
ochre mutation Mutation that changes any codon to the termination codon UAA.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á